id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-N-1862-0017,FDA,FDA-2020-N-1862,"The Drug Supply Chain Security Act  Pilot Project Program and Enhanced  Drug Distribution Security; Public 
Meeting",Notice,Request for Comments,2021-03-24T04:00:00Z,2021,3,2021-03-24T04:00:00Z,2021-06-23T03:59:59Z,2021-06-23T01:00:49Z,2021-06053,0,0,0900006484a768ec
FDA-2020-N-1862-0008,FDA,FDA-2020-N-1862,Request for Extension from The Association for Accessible Medicines (AAM),Other,Request for Extension,2020-12-21T05:00:00Z,2020,12,2020-12-21T05:00:00Z,,2020-12-21T17:14:31Z,,0,0,09000064849a9bf4
FDA-2020-N-1862-0005,FDA,FDA-2020-N-1862,Request for Extension from Healthcare Distribution Alliance (HDA),Other,Request for Extension,2020-12-04T05:00:00Z,2020,12,2020-12-04T05:00:00Z,,2020-12-04T18:14:06Z,,0,0,0900006484986a3a
FDA-2020-N-1862-0001,FDA,FDA-2020-N-1862,"The Drug Supply Chain Security Act Pilot Project Program and Enhanced
Drug Distribution Security; Public Meeting; Request for Comments",Notice,Request for Comments,2020-10-28T04:00:00Z,2020,10,2020-10-28T04:00:00Z,2020-12-29T04:59:59Z,2024-11-06T23:41:28Z,2020-23838,1,0,090000648493949a